Heavy Menstrual Bleeding associated with Uterine Fibroids
Efficacy and Safety of OBE2109 in Subjects with Heavy Menstrual Bleeding Associated with Uterine Fibroids
Study Length: 52 weeks
Target Age/Sex: 18 years and older, Female
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.